subcutaneous xenograft model

Pre-Clinical Cancer Models: Orthotopic and Heterotopic



Subcutaneous Xenograft models

Pharmaseed have extensive experience in evaluating anti-cancer drugs or therapies in order to show highly effective, and sometimes even spectacular anti-cancer treatment results using transplantable tumors in mice. These models involve human tumor xenografts grown subcutaneously in immune deficient hosts such as athymic (nude) or severe combined immune deficient (SCID) mice.

 

Multiple cancer models are available such as:

  • Colon
  • Breast
  • Melanoma
  • Liver
  • Lung
  • Pancreas

 

Anti-angiogenesis activity in solid xenogratft model

 

Subcutaneous Xenograft models services

 

EMT6/CTX  tumor cells were injected SC, 14 days post inoculation. tumor angiogenesis was assessed using Laser Doppler blood flow measurement for treated and unrelated mice.

For more information on how we can help you
move your drug or device along the development pathway.
Contact Us